Bart de Valk

Heterozygosity for a Hereditary Hemochromatosis Gene Is Associated With Cardiovascular Death in Women

Mark Roest, Yvonne T. van der Schouw, Bart de Valk et al. · Circulation · 1999 · 246 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 168 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients – A phase II trial

D.B.Y. Fontein, Ayoub Charehbili, J.W.R. Nortier et al. · European Journal of Cancer · 2014 · 85 citations

Medicine, Endocrinology, Oncology +13

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17